Pathophysiological Aspects of Gut Peptide Hormones

  • R. J. Playford
  • J. Calam
  • S. R. Bloom
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 106)


This chapter deals with the role of regulatory peptides in human disease states. The gastrointestinal tract is discussed starting at the esophagus and working anatomically downwards. A brief description of the normal anatomy and endocrine elements in each region is included. A more detailed description of the location of gastrointestinal peptides is given in Chap. 1.


Duodenal Ulcer Lower Esophageal Sphincter Vasoactive Intestinal Peptide Gastric Acid Secretion Gastrin Inhibitory Peptide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adrian TE, Long RG, Fuessl HS, Bloom SR (1985) Plasma peptide YY (PYY) in dumping syndrome. Dig Dis Sci 30:1145–1148PubMedGoogle Scholar
  2. Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Bestermann HS, Bloom SR (1986) Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 90:379–384PubMedGoogle Scholar
  3. Allison DJ (1978) Therapeutic embolisation. Br J Hosp Med 20:707–715PubMedGoogle Scholar
  4. Anderson L, Dockray GJ (1988) The cholecystokinin antagonist L364, 718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo. Eur J Pharmacol 146:307–311PubMedGoogle Scholar
  5. Behar J, Lee KY, Thompson WR, Biancani P (1989) Gall bladder contraction in patients with pigment and cholesterol stones. Gastroenterology 97:1479–1484PubMedGoogle Scholar
  6. Beardshall K, Frost G, Morarji Y, Domin J, Bloom SR, Calam J (1989) Saturation of fat and cholecystokinin release: implications for pancreatic carcinogenesis. Lancet 2:1008–1010PubMedGoogle Scholar
  7. Benito-Orfila MA, Playford RJ, Nandha K, Bloom SR (1990) Postprandial concentrations of peptide YY induce changes on VIP cardiovascular response. Brit. J Clin Pharmacol 31:613PGoogle Scholar
  8. Bennett A, Garrett JR, Howard ER (1968) Adrenergic myenteric nerves in Hirschsprung’s disease. Brit Med J 1:487–489PubMedGoogle Scholar
  9. Besterman HS, Bloom SR, Sarson DL, Blackburn AM, Johnston DI, Patel HR, Stewart JS, Modigliani R, Guerin S, Mauison CN (1978) Gut-hormone profile in coeliac disease. Lancet 1:785–788PubMedGoogle Scholar
  10. Besterman HS, Adrien TE, Mallinson CN, Christofides ND, Sarson DL, Pera A, Lombardo L, Modigliani R, Bloom SR (1982) Gut hormone release after intestinal resection. Gut 23:854–861PubMedGoogle Scholar
  11. Besterman HS, Christofides ND, Welby PD, Adrian TE, Sarson DL, Bloom SR (1983a) Gut hormones in acute diarrhoea. Gut 24:665–671PubMedGoogle Scholar
  12. Besterman HS, Mallinson CN, Modigliani R, Christofides ND, Pera A, Pontt V, Sarson DL, Bloom SR (1983b) Gut hormones in inflammatory bowel disease. Scand J Gastroenterol 18:845–852PubMedGoogle Scholar
  13. Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S (1980) Abnormalities of VIP containing nerves in Crohn’s disease. Gastroenterology 79:853–860PubMedGoogle Scholar
  14. Blackburn AM, Christofides ND, Ghatei M, Sarson DL, Ebeid FH, Ralphs DN, Bloom SR (1980) Elevation of plasma neurotensin in the dumping syndrome. Clin Sci 59:237–243PubMedGoogle Scholar
  15. Blair AJ, Feldman M, Barnett C, Walsh JM, Richardson CT (1987) Detailed comparison of basal and food stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. J Clin Invest 79:582–587PubMedGoogle Scholar
  16. Bloom SR (1980) Hormonal changes after jejuno ileal bypass and their physiological significance. In: Maxwell JD, Gazet JC, Pilkington TR (eds) Surgical management of obesity. Academic, London, pp 115–123Google Scholar
  17. Brand SJ, Stone D (1988) Reciprocal regulation of antral gastrin and somatostatin gene expression by omeprazole-induced achlorhydria. J Clin Invest 82: 1059–1066PubMedGoogle Scholar
  18. Calam J, Tracy HJ (1980) Pyloric reflux and gastrin cell hyperfunction. Lancet 2:918PubMedGoogle Scholar
  19. Calam J, Ellis A, Dockray G (1982) Identification and measurement of molecular variants of CCK in duodenal mucosa and plasma. J Clin Invest 69:218–225PubMedGoogle Scholar
  20. Calam J, Ghatei MA, Domin J, Adrian TE, Myszor M, Gupta S, Tait C, Bloom SR (1989) Regional differences in concentrations of regulatory peptides in human colonic mucosal biopsies. Dig Dis Sci 34:1193–1198PubMedGoogle Scholar
  21. Calam J, Yiangou Y, Nikou GC, Chrysanthou BJ, Beacheman JL, Bloom SR (1990) Effects of preprovasoactive intestinal polypeptide derived peptides on ileal output. Gastroenterology 98:505–508PubMedGoogle Scholar
  22. Calam J, Goodlad RA, Lee CY et al. (1991) Achlorhydria-indueed hyper-gastrinaemia: the role of bacteria. Clin Sci 80:281–284PubMedGoogle Scholar
  23. Caldara R, Grimaldi MG, Barbieri C, Grimaldi MG, Barbieri C, Ferrari C (1981) Serum gastrin concentration in patients with rheumatoid arthritis: effect of long-term immunosuppressive or antidopaminergic treatment. Horm Metab Res 13:615–617PubMedGoogle Scholar
  24. Cantor P, Olsen O, Schaffalitzky de Muckadell OB, Jodal M (1988) Effect of trypsin on the hormonal regulation of fat stimulated exocrine secretion. Biomed Res Suppl 1:A25Google Scholar
  25. Cassella RR, Ellis FH, Brown AL (1965) Fine structure changes in achalasia of the eosophagus. I. Vagus nerves. Am J Pathol 46:279–288PubMedGoogle Scholar
  26. Cassuto J, Fahrenkrug J, Jodal M, Tuttle R, Lundgren O (1981) Release of vasoactive intestinal polypeptide from the cat small intestine exposed to cholera toxin. Gut 22:958–963PubMedGoogle Scholar
  27. Cave DR, Vargas M (1989) Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 2:187–189PubMedGoogle Scholar
  28. Chey WY, Chang TM, Lee KY, Sun G, Kim CK, You Ch, Hamilton DL, Shah A, Rhee JC, Mutt V, (1989) Ulcerogenic tumour syndrome of the pancreas associated with a non-gastrin secretogogue. Ann Surg 210:140–149Google Scholar
  29. Chian HCV, O’Dorisio TM, Huang SC, Maton PN, Gardner JD, Jensen RT (1990) Multiple hormone elevations in Zollinger Ellison syndrome. Gastroenterology 99:1565–1575Google Scholar
  30. Chicone L, Narayan S, Townsend CM, Singh P (1989) The presence of a 33–40 KDa gastrin binding protein on human and mouse colon cancer. Biochem Biophys Res Commun 164:512–519PubMedGoogle Scholar
  31. Cohen S (1973) Hypogastrinaemia and sphincter incompetence. N Engl J Med 289:215–217PubMedGoogle Scholar
  32. Cooper RG, Dockray GJ, Calam J, Walker R (1985) Acid and gastrin responses during intragastric titration in normal and DU patients with G-cell hyper-function. Gut 26:232–236PubMedGoogle Scholar
  33. Crabtree JE, Shallcross TM, Wyatt JI, Meatley RV (1990) Tumour necrosis factor alpha secretion by Helicobacter pylori colonised gastric mucosa. Gut 31: A600–A601Google Scholar
  34. Creutzfeldt W, Arnold R, Creutzfeldt C, Track NS (1975) Pathomorphological aspects, biochemical and diagnostic aspects of gastrinomas. Hum Pathol 6:47–76PubMedGoogle Scholar
  35. DelValle J, Yamada T (1990) Amino acids and amines stimulate gastrin release from canine antral G cells via different pathways. Clin Invest 85:139–143Google Scholar
  36. Denizot Y, Sobhani I, Rambaud JC, Lewin M, Thomas Y, Beneviste J (1990) PAF aceter synthesis by Helicobacter pylori. Gut 31:1242–1245PubMedGoogle Scholar
  37. De Witte TJ, Geerdink PJ, Lamers CB, Boerbooms AM, Van der Karst JK (1979) Hypochlorhydria and hypergastrinaemia in rheumatoid arthritis. Ann Rheum Dis 38:14–17PubMedGoogle Scholar
  38. Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Amdorfer RC (1981) Paradoxical lower oesophageal sphincter contraction induced by CCK-8 in patients with achalasia. Gastroenterology 80:327–333PubMedGoogle Scholar
  39. Dooley CP, Cohen H (1988) The clinical significance of Campylobacter pylori. Ann Intern Med 108:70–79PubMedGoogle Scholar
  40. Douglas BR, Wouterson RA, Jansen JM, de Jong AJ, Rovati LC, Lamers CB (1989) Modulation by CR-1409 a cholecystokinin antagonist of trypsin inhibitor enhanced growth of azaserine induced putative preneoplastic lesions in rat pancreas. Cancer Res 498:2438–2441Google Scholar
  41. Ehrenpreis T, Pernow B (1953) On the occurrence of substance P in the rectosigmoid junction in Hirschsprungs disease. Acta Physiol Scand 27:380–388PubMedGoogle Scholar
  42. Eklund S, Farenkrug F, Jodal M, Lundgren O, Schaffalitzky de Muckadell OB, Sjöqvist A (1980) Vasoactive intestinal polypeptide, 5-hydroxytryptamine and reflex hyperaemia in the small intestine of the cat. J Physiol (Lond) 302:549–557Google Scholar
  43. Eklund S, Jodal M, Lundgren O (1985) The enteric nervous system participates in the secretory response to the heat stable enterotoxins of Escherichia coli in rats and cats. Neuroscience 14:673–681PubMedGoogle Scholar
  44. Ellison EH (1964) The ZE syndrome: reappraised and evaluation of 260 registered cases. Ann Surg 160:512–530PubMedGoogle Scholar
  45. El-Nujumi AM, Dorian CA, Chittajalla RS, Neithercut WD, McColl KE (1991) Effect of inhibition of H. pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects. Gut 32:866–870PubMedGoogle Scholar
  46. Everson GT, McKinley C, Lawson M, Johnson M, Kern F Jr (1982) Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy, and contraceptive steroids. Gastroenterology 82:711–719PubMedGoogle Scholar
  47. Fahrenkrug J, Pedersen JH (1986) Cosecretion of PHM and VIP in patients with VIP producing tumours. Peptides 7:717–721PubMedGoogle Scholar
  48. Figura N, Guglielmetti P, Rossolini A, Barberi A, Cusi G, Musmanno RA, Russi M, Quaranta S (1989) Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and patients with gastritis only. J Clin Microbiol 27:225–226PubMedGoogle Scholar
  49. Fisher RS, Rock E, Malmud LS (1986) Gallbladder emptying response to sham feeding in humans. Gastroenterology 90:1854–1857PubMedGoogle Scholar
  50. Folsch UR, Winkler K, Wormsley KG (1978) Influence of repeated administration of CCK and secretin on the pancreas of the rat. Scand J Gastroenterol 13:663–671PubMedGoogle Scholar
  51. Forgacs IC, Maisey MN, Murphy GM, Dowling RH (1984) Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying. Gastroenterology 87:299–307PubMedGoogle Scholar
  52. Fox PS, Hofmann JW, Decosse JJ, Wilson SD (1974) The influence of total gastrectomy on survival in malignant Zollinger Ellison syndrome. Ann Surg 180:558–566PubMedGoogle Scholar
  53. Freund HR, Humphrey CS, Fischer JE (1979) Reduced tissue content of VIP in aganglionic colon of Hirschsprung’s disease. Gastroenterology 76:1135Google Scholar
  54. Funakoshi A, Tateishi K, Shinozaki H, M. Yashaka K, Ito T, Wakasugi H (1990) Plasma pancreastatin responses after intrajejunal infusion of liquid meal in patients with chronic pancreatitis. Dig Dis Sci 35:721–725PubMedGoogle Scholar
  55. Gear MWL, Truelove SC, Whitehead R (1971) Gastric ulcer and gastritis. Gut 12:639–645PubMedGoogle Scholar
  56. Gerber BC (1960) Simultaneous duodenal carcinoma and non-beta cell tumours of the pancreas. Arch Surg 81:379–388PubMedGoogle Scholar
  57. Goodwin CS (1988) Duodenal ulcer, Campylobacter pylori and the “leaking roof” concept. Lancet 2:1467–1469PubMedGoogle Scholar
  58. Gordis, Gold EB (1984) Epidemiology of pancreatic cancer. World J Surg 8:808–821PubMedGoogle Scholar
  59. Goyal RK, Ratten S, Said SI (1980) VIP as a possible neurotransmitter of non-cholinergic, non-adrenergic inhibitory neurones. Nature 288:378–380PubMedGoogle Scholar
  60. Harris AG (1990) Future medical prospects for Sandostatin. Metabolism 39 Suppl 2:180–185Google Scholar
  61. Harvey RF, Read AE (1973) Effect of CCK on colonic motility and symptoms in patients with the irritable bowel syndrome. Lancet 1:1PubMedGoogle Scholar
  62. Hoosein NM, Keiner PA, Currey RC, Brattain MG (1990) Evidence for autocrine growth stimulation of cultured colon tumour cells by a gastrin/CCK-like peptide. Exp Cell Res 186:15–21PubMedGoogle Scholar
  63. Hopman WP, Jansen JB, Rosenbusch G, Lamers CB (1987) Cephalic stimulation of gallbladder contraction in humans: role of cholecystokinin and the cholinergic system. Digestion 38:197–203PubMedGoogle Scholar
  64. Hubel K (1972) Secretin: a long progress note. Gastroenterology 62:318–341PubMedGoogle Scholar
  65. Ingelfinger FJ (1958) Esophageal motility. Physiol Rev 38:533–584PubMedGoogle Scholar
  66. Iwai K, Fukuoka SI, Fushiki M, Tsujikawa M, Hirose M, Tsunasawa S, Sakiyama F (1987) Purification and sequencing of a trypsin sensitive cholecystokinin releasing peptide from rat pancreatic juice: its homology with pancreatic secretory trypsin inhibitor. J Biol Chem 262:8956–8959PubMedGoogle Scholar
  67. Johnson HD, Love AHG, Rogers NC, Wyatt AP (1964) Gastric ulcers, blood groups and acid secretion. Gut 5:402–405PubMedGoogle Scholar
  68. Kelbaek H, Munck O, Christensen NJ, Godtfredsen J (1989) Central haemodynamic effects after a meal. Br Heart J 61:506–509PubMedGoogle Scholar
  69. Koch TR, Michener SR, Go VL (1991) Plasma VIP concentration determination in patients with diarrhoea. Gastroenterology 100:99–106PubMedGoogle Scholar
  70. Koide M, Okabayashi Y, Hasegawa H, Tani S, Fujisawa T, Nakamura T, Fujii M, Otsuki M (1989) Plasma cholecystokinin concentrations in patients with chronic pancreatitis measured by bioassay. Nippon Shokakibyo Gakkai Zasshi 86: 2419–2424PubMedGoogle Scholar
  71. Kooner JS, Peart WS, Mathias CJ (1989) The peptide release inhibitor, Octreotide (SMS 201–995), prevents the haemodynamic changes following food ingestion in normal human subjects. Q J Exp Physiol 74:569–572PubMedGoogle Scholar
  72. Koop I, Koop H, Gerhardt C, Schafmaner A, Arnold R (1989) Do bile acids exert a negative feedback control of CCK release? Scand J Gastroenterol 24:315–320PubMedGoogle Scholar
  73. Kramer P, Ingelfinger FJ (1951) Esophageal sensitivity to metholyl in cardiospasm. Gastroenterology 19:242PubMedGoogle Scholar
  74. Krejs GJ, Browne R, Raskin P (1980) Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water and electrolytes. Gastroenterology 78:26–31PubMedGoogle Scholar
  75. Lamberts R, Creutzfeldt W, Stockman F, Jacubaschke V, Maas S, Brunner G (1988) Long term omeprazole treatment in man. Digestion 39:126–135PubMedGoogle Scholar
  76. Lanzon-Millar S (1987) Twenty four hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranidine or omeprazole. Aliment Pharmacol Ther 1:239–251Google Scholar
  77. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskjold M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85–87PubMedGoogle Scholar
  78. Larsson H, Carlsson E, Hakanson R, Mattsson H, Nilsson-Seensalu R, Wallmark B, Sundler F (1988) Time course of development and, reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Gastroenterology 95: 1477–1486PubMedGoogle Scholar
  79. La Vecchia C (1990) Histamine-2-receptor antagonists and gastric cancer risk. Lancet 336:355–357PubMedGoogle Scholar
  80. Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR (1988) Cytotoxic activity in broth culture filtrates of Campylobacter pylori. J Med Microbiol 26:93–99PubMedGoogle Scholar
  81. Levi S, Beardshall K, Swift I, Foulkes W, Playford RJ, Gosh P, Calam J (1989a) Antral Campylobacter pylori, hypergastrinaemia and duodenal ulcers effect of eradicating the organism. Br Med J 299:1504–1505Google Scholar
  82. Levi S, Beardshall K, Haddad G, Playford RJ, Gosh P, Calam J (1989b) Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1:1167–1168PubMedGoogle Scholar
  83. Liddle RA, Gertz BJ, Kanayama S, Beccaria L, Coker LD, Turnbull TA, Morita ET (1989) Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. J Clin Invest 84:1220–1225PubMedGoogle Scholar
  84. Lipschutz WH, Cohen S (1971) Physiological determinants of lower esophagal sphincter function. Gastroenterology 61:16–24Google Scholar
  85. Long RG, Bishop AE, Barnes AJ, Albuguergne RH, O’Shaughnessy DJ, McGregor GP, Baunister R, Polak JM, Bloom SR (1980) Neural and hormonal peptides in rectal biopsy specimens from patients with Chagas’ disease. Lancet 1:559–562PubMedGoogle Scholar
  86. Long RG, Bryant MG, Mitchell SJ, Adrian TE, Polak JM, Bloom SR (1981) Clinicopathological study of pancreatic and ganglioblastoma tumour-secreting VIP (VIPomas). Br Med J 282:1767–1771Google Scholar
  87. Mai UEH, Perz GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD (1990) Inflammatory and cytoprotective response by human monocytes are induced by Helicobacter pylori. Gastroenterology 98:A662Google Scholar
  88. Marshal BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackboorn SJ, Phillips M, Waters TE, Sanderson CR (1988) Prospective double blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2: 1439–1441Google Scholar
  89. Masclee AA, Jansen JB, Driessen WM, Geuskens LM, Lamers CB (1989) Plasma cholecystokinin and gallbladder responses to intraduodenal fat in gallstone patients. Dig Dis Sci 34:353–359PubMedGoogle Scholar
  90. Maton PN, Gardner JD, Jensen RT (1989) Use of long-acting somatostatin analog SMS 201–995 in patients with pancreatic islet cell tumors. Dig Dis Sci 34 Suppl 3:28S–39SPubMedGoogle Scholar
  91. McColl KE, Fullarton GM, El-Nujumi AM, Macdonald AM, Brown IL, Hilditch TE (1989) Lowered gastric acidity and gastrin after eradication of Campylobacter pylori in duodenal ulcer. Lancet 2:499–500PubMedGoogle Scholar
  92. McColl KEL, Fullarton GM, El-Nujumi AM, MacDonald AMI, Dahil S, Hilditch TE (1990) Serum gastrin and gastric acid status one and seven months after eradication of Helicobacter pylori in duodenal ulcer patients. Gut 31:A601Google Scholar
  93. McGuigan JE, Wolfe MM (1980) Secretin injection test in the diagnosis of gastrinoma. Gastroenterology 79:1324–1331PubMedGoogle Scholar
  94. Messing B, Bories C, Kunstlinger F, Messing B, Bories C, Kunstlinger F, Bernier JJ (1983) Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology 84:1012–1019PubMedGoogle Scholar
  95. Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JB, Zach D, Rovati LC, Stadler G A (1989) Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1:12–15Google Scholar
  96. Michelangeli F, Ruiz MC, Rodriguez CL, Relacca A (1988) Somatostatin inhibition of secretagogue and forskolin-stimulated gastric acid secretion. Am J Physiol 254:G531–G537PubMedGoogle Scholar
  97. Nemeth J, Taylor BA, Dockray GJ (1992) Human colonic cancers contain gastrin precursor. Gut (in press)Google Scholar
  98. Orme ML, Dockray GJ, Baber N, Sibeon RG, Malliday LD, Littler TR (1979) The effects of indomethacin on serum gastrin concentrations (Letter). Ann Rheum Dis 38:578PubMedGoogle Scholar
  99. Owyang C, May D, Louie DS (1986) Trypsin suppression of pancreatic enzyme secretion. Gastroenterology 91:637–643PubMedGoogle Scholar
  100. Pipeleers-Marichal M, Somers G, Willems G, Foulis A, Jmrie C, Bishop AE, Polak JM, Hacki WH, Stamm B, Heitz PU (1990) Gastrinomas in the duodenum of patients with multiple endocrine neoplasia type 1 and the Zollinger Ellison syndrome. N Engl J Med 322:723–727PubMedGoogle Scholar
  101. Playford RJ, Domin J, Beecham J, Parmar KB, Tatemoto K, Bloom SR, Calam J (1990) Peptide YY: a natural defence against diarrhoea. Lancet 335:1555–1557PubMedGoogle Scholar
  102. Polak JM, Bloom SR (1982) Regulatory peptides in the gut and their relevance to disease. In: Crow TJ (ed) Disorders of neuroendocrine transmission. Academic, London, pp 83–104Google Scholar
  103. Primrose N, Ratcliffe JG, Joffee SN (1985) Differences between peptic ulcer and control patients on the basis of response to secretin. Digestion 32:249–254PubMedGoogle Scholar
  104. Ramo OJ, Puolakkainen PA, Seppala K, Schroder TM (1989) Self-administration of enzyme substitution in the treatment of exocrine pancreatic insufficiency. Scand J Gastroenterol 24:688–692PubMedGoogle Scholar
  105. Rhodes J, Barnado DE, Sidney MB, Philips SF (1969) Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology 57:241–252PubMedGoogle Scholar
  106. Richards AT, Hinder RA, Harrison AC (1987) Gastric carcinoid tumours associated with hypergastrinaemia and pernicious anaemia — regression of tumours by antrectomy. S Afr Med J 72:51–54PubMedGoogle Scholar
  107. Roebuck BD, Yager JD, Longnecker DS, Wilpone SA (1981) Promotions by unsaturated fat of azaserine-induced pancreatic carcinogenesis in the rat. Cancer Res 41:3961–3966PubMedGoogle Scholar
  108. Ruskone A, Rene E, Chayvialle JA, Bonin N, Pignal F, Kremer M, Bonfils S, Ramband JC (1982) Effects of somatostatin on diarrhoea and on small intestinal water and electrolyte transport. Dig Dis Sci 27:459PubMedGoogle Scholar
  109. Sagor GR, Bryant MG, Ghatei MA, Kirk RM, Bloom SR (1981) Release of vasoactive intestinal peptide in the dumping syndrome. Br Med J [Clin Res] 282: 507–510Google Scholar
  110. Sakamoto T, Miyata M, Hamaji M, Sakaguchi H, Tanaka Y, Hashimoto T, Kawashima Y (1990) Beta adrenergic regulation of gastrin release from gastrinoma cells. Surgery 107:282–288PubMedGoogle Scholar
  111. Servin AL, Rouyer-Fessard C, Balasubramaniam A, Saint-Pierre S, Laburthe M (1989) Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3′, 5′-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors. Endocrinology 124:692–700PubMedGoogle Scholar
  112. Shinya H, Fujimura M (1989) Possible role of cholecystokinin in the development of acute pancreatitis in rats. Nippon Geka Hokan 58:3–17PubMedGoogle Scholar
  113. Skak-Nielson T, Holst JJ, Nielson OV (1988) Role of GRP in the neural control of pepsinogen secretion from the pig stomach. Gastroenterology 95:1216–1220Google Scholar
  114. Smith JP, Wood JG, Solomen TE (1989) Elevated gastrin levels in patients with colon cancer or adenomatous polyps. Dig Dis Sci 34:171–174PubMedGoogle Scholar
  115. Spengler U, Sackmann M, Sauerbruch T, Holl J, Paumgartner G (1989) Gallbladder motility before and after extracorporeal shock-wave lithotripsy. Gastroenterology 96:860–863PubMedGoogle Scholar
  116. Stone BG, Gavaler JS, Belle SH, Shreiner DP, Peleman RR, Sarra RP, Yingvorapant N, Vanthiel DH (1988) Impairment of gallbladder emptying in diabetes mellitus. Gastroenterology 95:170–176PubMedGoogle Scholar
  117. Stremple JF (1974) Serum gastrin levels in reflux oesophagitis. Gastroenterology 66:A131Google Scholar
  118. Sturdevant RAL (1974) Is gastrin the major regulator of lower esophageal sphincter pressure? Gastroenterology 67:551–553PubMedGoogle Scholar
  119. Svendsen JH, Dahl C, Svendsen LB, Christiansen PM (1986) Gastric cancer risk in achlorhydric patients. A long-term follow-up study. Scand J Gastroenterol 21: 16–20PubMedGoogle Scholar
  120. Sylwestrowicz TA, Shaffer EA (1988) Gallbladder function during gallstone dissolution. Effect of bile acid therapy in patients with gallstones. Gastroenterology 95:740–748PubMedGoogle Scholar
  121. Tally NJ, DiMagno E, Zinsmeister AR, Blaser M (1990) Helicobacter pylori and gastric cancer: a case controlled study. Enferm Dig 78 Suppl:O11Google Scholar
  122. Tatemoto K (1982) Isolation and characterisation of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 79:2514–2518PubMedGoogle Scholar
  123. Teichman K, Grab P, Hammer C, Brendel W (1986) Gastrin release by interleukin 2 and gamma interferon in vitro. Can J Physiol Pharmacol 64 Suppl:62Google Scholar
  124. Uddman R, Alumets J, Edvinsson L, Hakanson R, Sundler F, (1978) Peptidergic (VIP) innervation of the eosophagus. Gastroenterology 75:5–8PubMedGoogle Scholar
  125. Van Erpecum KJ, van Berge Henegouwen GP, Stolk MF, Hopman WP, Jansen JB, Lamers CB (1990) Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects. Gastroenterology 99:836–842PubMedGoogle Scholar
  126. Vassallo G, Solcia E, Bussolati G, Polak JM, Pearse AG (1972) Non G-cell gastrin producing tumours of the pancreas. Virchows Arch [B] 11:66–79Google Scholar
  127. Walan A, Bader JP, Classen M, Lamers CB, Piper DW, Rutgersson K, Eriksson S (1989) Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcers. N Engl J Med 320:69–73PubMedGoogle Scholar
  128. Walsh JH, Richardson CT, Fordtran JS (1975) pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 55:462–468PubMedGoogle Scholar
  129. Wider M, Lu L, Owyang C (1988) Extraction and characterisation of a CCK-releasing peptide mediating feedback regulation of pancreatic secretion (Abstr). Biomed Res 9 Suppl 1:54Google Scholar
  130. Williams JA, Goldfine ID (1985) Insulin-pancreatic acinar axis. Diabetes 34:980–986PubMedGoogle Scholar
  131. Wong K, Beardshall K, Calam J, Poston GJ (1990) Postprandial hypergastrinaemia in patients with colorectal cancer. Gut 31:A1166Google Scholar
  132. Wyatt JI, Rathbone BJ, Green DM, Primrose J (1989) Raised fasting serum gastrin in chronic gastritis is independent of Campylobacter pylori status and duodenal ulcer. Gut 30:A1483Google Scholar
  133. Wynder EL (1975) An epidemiological evaluation of the causes of cancer of the pancreas. Cancer Res 35:2228–2233PubMedGoogle Scholar
  134. Wynick D, Williams SJ, Bloom SR (1988) Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumours. N Engl Med 319:605–609Google Scholar
  135. Zollinger RM (1975) Islet cell tumours of the pancreas and alimentary tract. Am J Surg 129:102–110PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • R. J. Playford
  • J. Calam
  • S. R. Bloom

There are no affiliations available

Personalised recommendations